<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39498233</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-8293</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The journal of allergy and clinical immunology. Global</Title><ISOAbbreviation>J Allergy Clin Immunol Glob</ISOAbbreviation></Journal><ArticleTitle>Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections.</ArticleTitle><Pagination><StartPage>100340</StartPage><MedlinePgn>100340</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100340</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacig.2024.100340</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in March 2020 led to the implementation of nonpharmaceutical interventions (NPIs) to curb its spread. Studies have shown that adult asthma exacerbations and viral infections decreased during NPI use. However, few studies have shown the effects of NPIs on pediatric asthma exacerbations and infections during and after the pandemic.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aimed to understand the impact of NPIs on asthma exacerbations and viral respiratory infections in pediatric patients at our institution from March 2018 to December 2022.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The medical record numbers of children with asthma exacerbations seen at our institution between March 2018 and December 2022 were analyzed. Subjects were categorized on the basis of timing of their exacerbation in relation to NPI enforcement. We used the results from clinical testing with the BioFire Respiratory Panel (BRP) to detect up to 22 respiratory pathogens and then correlated these results with asthma exacerbation severity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">There were 5,758 asthma exacerbations recorded, with a 50% decline in average weekly exacerbations during NPI enforcement. Of the 70,682 BRP tests performed, 87% returned a positive result for at least 1 pathogen. Several viruses (respiratory syncytial virus, parainfluenza, and influenza) had a decrease in positivity rate with NPIs, whereas rhinovirus/enterovirus positivity rates were unchanged throughout the pandemic. Asthma exacerbations with a positive BRP result required higher clinical levels of care during the admission.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">NPIs were associated with significantly reduced numbers of asthma exacerbations and respiratory viral infections. The post-NPI period saw a return to prepandemic levels of asthma exacerbations and an unusual surge in respiratory syncytial virus infections, emphasizing the need for continuous monitoring and adaptive strategies in the postpandemic landscape.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caid</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tate</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousuf</LastName><ForeName>Shahwar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Lillian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesek</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jefferson</LastName><ForeName>Akilah A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Tamara T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioinformatics, Arkansas Children's Hospital, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingold</LastName><ForeName>Ashton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartzell</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyanton</LastName><ForeName>Bobby L</ForeName><Initials>BL</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Pathology, Arkansas Children's Hospital and University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobb</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Haley</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>House</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frederick</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frenner</LastName><ForeName>Rachel A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Pathology, Arkansas Children's Hospital and University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hathorn</LastName><ForeName>Erin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Arkansas Children's Hospital, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Joshua L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arkansas Children's Research Institute, Little Rock, Ark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Ark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol Glob</MedlineTA><NlmUniqueID>9918453488706676</NlmUniqueID><ISSNLinking>2772-8293</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nonpharmaceutical interventions</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">asthma exacerbations</Keyword><Keyword MajorTopicYN="N">pediatric asthma</Keyword><Keyword MajorTopicYN="N">viral infections</Keyword></KeywordList><CoiStatement>Supported by the Center for Translational Pediatric Research (10.13039/100000002National Institutes of Health/10.13039/100000057National Institute of General Medical Sciences [P20GM121293 Team Science and COVID-19 Variant Sequencing supplements (to J.L.K., S.H., G.T., A.I., and D.F.)]), the 10.13039/501100020492Translational Research Institute (National Institutes of Health/National Center for Advancing Translational Sciences [grant UL1TR003107 (to J.L.K.)]), the Arkansas Children’s Research Institute (to J.L.K.), the 10.13039/100008231Arkansas Biosciences Institute (to J.L.K.), NIH/NHLBI R01HL173573 (to J.K.L.) and the National Center For Advancing Translational Sciences of the National Institutes of Health (awards KL2 TR003108 and UL1 TR003107 [to A.A.J.]). Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>4</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39498233</ArticleId><ArticleId IdType="pmc">PMC11533078</ArticleId><ArticleId IdType="doi">10.1016/j.jacig.2024.100340</ArticleId><ArticleId IdType="pii">S2772-8293(24)00136-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronavirus (COVID-19) dashboard. World Health Organization. https://covid19.who.int/ Available at:</Citation></Reference><Reference><Citation>Nonpharmaceutical interventions (NPIs). US Centers for Disease Control and Prevention. 2017. https://www.cdc.gov/nonpharmaceutical-interventions/index.html Updated October 3, 2022. Available at:</Citation></Reference><Reference><Citation>Guidance for COVID-19 prevention and control in schools. Inter-Agency Standing Committee with the World Health Organization. 2020. https://data2.unhcr.org/en/documents/details/74755 Available at:</Citation></Reference><Reference><Citation>COVID-19 government response tracker. University of Oxford. 2020. https://www.bsg.ox.ac.uk/research/covid-19-government-response-tracker Available at:</Citation></Reference><Reference><Citation>Chiu S.S., Cowling B.J., Peiris J.S.M., Chan E.L.Y., Wong W.H.S., Lee K.P. Effects of nonpharmaceutical COVID-19 interventions on pediatric hospitalizations for other respiratory virus infections, Hong Kong. Emerg Infect Dis. 2022;28:62–68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8714236</ArticleId><ArticleId IdType="pubmed">34932446</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Xu M., Cao L., Su L., Lu L., Dong N., et al. Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China. Virol J. 2021;18:159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8329611</ArticleId><ArticleId IdType="pubmed">34344406</ArticleId></ArticleIdList></Reference><Reference><Citation>Diesner-Treiber S.C., Voitl P., Voitl J.J.M., Langer K., Kuzio U., Riepl A., et al. Respiratory infections in children during a COVID-19 pandemic winter. Front Pediatr. 2021;9:740–785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8558488</ArticleId><ArticleId IdType="pubmed">34733808</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q.S., Wood T., Jelley L., Jennings T., Jeffries S., Daniells K., et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12:1001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>Partridge E., McCleery E., Cheema R., Nakra N., Lakshminrusimha S., Tancredi D.J., et al. Evaluation of seasonal respiratory virus activity before and after the statewide COVID-19 shelter-in-place order in Northern California. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835714</ArticleId><ArticleId IdType="pubmed">33492377</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed S., Diwadkar A.R., Dudley J.W., O’Brien J., Dvorin D., Kenyon C.C., et al. COVID-19 Pandemic-related reductions in pediatric asthma exacerbations corresponded with an overall decrease in respiratory viral infections. J Allergy Clin Immunol Pract. 2022;10:91–99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590625</ArticleId><ArticleId IdType="pubmed">34785388</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer G., Braunstahl G.J., Hendriks R., Tramper-Stranders G. Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort. BMJ Open Respir Res. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102860</ArticleId><ArticleId IdType="pubmed">33952584</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore W.C., Ledford D.K., Carstens D.D., Ambrose C.S. Impact of the COVID-19 pandemic on incidence of asthma exacerbations and hospitalizations in US subspecialist-treated patients with severe asthma: results from the CHRONICLE study. J Asthma Allergy. 2022;15:1195–1203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9441176</ArticleId><ArticleId IdType="pubmed">36068863</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Miyawaki A., Nakamura M., Ninomiya H., Kobayashi Y. Trends in hospitalizations for asthma during the COVID-19 outbreak in Japan. J Allergy Clin Immunol Pract. 2021;9:494–496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553873</ArticleId><ArticleId IdType="pubmed">33065368</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S.A., Quint J.K., Sheikh A. Impact of COVID-19 pandemic on asthma exacerbations: retrospective cohort study of over 500,000 patients in a national English primary care database. Lancet Reg Health Eur. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9213032</ArticleId><ArticleId IdType="pubmed">35756853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreger J.E., Hershenson M.B. Effects of COVID-19 and social distancing on rhinovirus infections and asthma exacerbations. Viruses. 2022;14:2340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9698629</ArticleId><ArticleId IdType="pubmed">36366439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst J.H., Zhao C., Fitzpatrick N.S., Goldstein B.A., Lang J.E. Reduced pediatric urgent asthma utilization and exacerbations during the COVID-19 pandemic. Pediatr Pulmonol. 2021;56:3166–3173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441648</ArticleId><ArticleId IdType="pubmed">34289526</ArticleId></ArticleIdList></Reference><Reference><Citation>Salciccioli J.D., She L., Tulchinsky A., Rockhold F., Cardet J.C., Israel E. Effect of COVID-19 on asthma exacerbation. J Allergy Clin Immunol Pract. 2021;9:2896–2899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086260</ArticleId><ArticleId IdType="pubmed">33940216</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantu R.M., Sanders S.C., Turner G.A., Snowden J.N., Ingold A., Hartzell S., et al. Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections. MedRxiv. 2023 doi: 10.1101/2023.03.29.23287924. Accessed May 31, 2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.03.29.23287924</ArticleId><ArticleId IdType="pmc">PMC11446435</ArticleId><ArticleId IdType="pubmed">39356708</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquechel K., Diwadkar A.R., Sayed S., Dudley J.W., Grundmeier R.W., Kenyon C.C., et al. Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8:3378–3387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438361</ArticleId><ArticleId IdType="pubmed">32827728</ArticleId></ArticleIdList></Reference><Reference><Citation>Akelma Z., Çetin S., Başkaya N., Bostancı İ., Özmen S. Preschool children with asthma during the Covid-19 pandemic: fewer infections, less wheezing. J Asthma. 2023;60:691–697.</Citation><ArticleIdList><ArticleId IdType="pubmed">35696321</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson K.E., McGinty E.E., Presskreischer R. Reports of foregone medical care among US adults during the initial phase of the COVID-19 pandemic. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7821029</ArticleId><ArticleId IdType="pubmed">33475757</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrun-Harris L.A., Sappenfield O.R., Warren M.D. Missed and delayed preventive health care visits among US children due to the COVID-19 pandemic. Public Health Rep. 2021;137:336–343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900224</ArticleId><ArticleId IdType="pubmed">34969335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazdar S., van den Berg S., Rutjes N.W., Bloemsma L.D., Downward G.S., De Weger L.A., et al. The effects of the COVID-19 pandemic on PICU admissions for severe asthma exacerbations: a single-center experience. Pediatr Pulmonol. 2024;59:263–273.</Citation><ArticleIdList><ArticleId IdType="pubmed">37937901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich L., Yell J., Holtzlander M. Asthma medication use and health care utilization evolution during pandemic times. Pediatr Pulmonol. 2023;58:2757–2760.</Citation><ArticleIdList><ArticleId IdType="pubmed">37401870</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton P.N., Hu N., Saravanos G., Shrapnel J., Davis J., Snelling T., et al. COVID-19 public health measures and respiratory syncytial virus. Lancet Child Adolesc Health. 2020;4:e42–e43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500894</ArticleId><ArticleId IdType="pubmed">32956616</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymann P.W., Carper H.T., Murphy D.D., Platts-Mills T.A., Patrie J., McLaughlin A.P., et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004;114:239–247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185400</ArticleId><ArticleId IdType="pubmed">15316497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kırca F., Aydoğan S., Gozalan A., Güler E., Uyan Erten A.Z., Özşen Uygur A.S., et al. Impact of nonpharmaceutical interventions on circulating respiratory viruses during the COVID-19 pandemic in Turkey. Ann Saudi Med. 2023;43:143–153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10317495</ArticleId><ArticleId IdType="pubmed">37270680</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolores A., Stephanie G., Mercedes S.N.J., Érica G., Mistchenko A.S., Mariana V. RSV reemergence in Argentina since the SARS-CoV-2 pandemic. J Clin Virol. 2022;149</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906024</ArticleId><ArticleId IdType="pubmed">35299101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern J.E., Busse W.W. 1999.Association of rhinovirus infections with asthma. Clin Microbiol Rev. 1999;12:9–18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88904</ArticleId><ArticleId IdType="pubmed">9880472</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley D.A., Phuong L.K., Peplinski J., Lim S.M., Lee W.H., Farhat A., et al. Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia. Arch Dis Child. 2022;107</Citation><ArticleIdList><ArticleId IdType="pubmed">34433552</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardsley M., Morbey R.A., Hughes H.E., Beck C.R., Watson C.H., Zhao H., et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. 2023;23:56–66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9762748</ArticleId><ArticleId IdType="pubmed">36063828</ArticleId></ArticleIdList></Reference><Reference><Citation>Dick E.C., Jennings L.C., Mink K.A., Wartgow C.D., Inhorn S.L. Aerosol transmission of rhinovirus colds. J Infect Dis. 1987;156:442–448.</Citation><ArticleIdList><ArticleId IdType="pubmed">3039011</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrup L., Krogfelt K.A., Hansen K.S., Madsen A.M. Transmission route of rhinovirus - the causative agent for common cold. A systematic review. Am J Infect Control. 2023;51:938–957.</Citation><ArticleIdList><ArticleId IdType="pubmed">36535318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinwiddie D.L., Kaukis N., Pham S., Hardin O., Stoner A.N., Kincaid J.C., et al. Viral infection and allergy status impact severity of asthma symptoms in children with asthma exacerbations. Ann Allergy Asthma Immunol. 2022:319–326.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10091837</ArticleId><ArticleId IdType="pubmed">35750292</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D.J., Busse W.W., Bacharier L.B., Kattan M., O’Connor G.T., Wood R.A., et al. Association of respiratory allergy, asthma, and expression of SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146:203–206.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175851</ArticleId><ArticleId IdType="pubmed">32333915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich L., Macias C., George A., Bai S., Allen E. Unexpected decline in pediatric asthma morbidity during the coronavirus pandemic. Pediatr Pulmonol. 2021;56:1951–1956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251009</ArticleId><ArticleId IdType="pubmed">33848402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho T., Shahzad A., Jones A., Raghavan N., Loeb M., Johnston N. Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus. Thorax. 2023;78:1248–1253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715522</ArticleId><ArticleId IdType="pubmed">37423763</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>